A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice
- PMID: 24976983
- PMCID: PMC4073381
- DOI: 10.3978/j.issn.2072-1439.2014.04.12
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice
Abstract
Objectives: Polymerase chain reaction (PCR) for the detection of Mycobacterium tuberculosis (MTB) is more sensitive, specific, and rapid than the conventional methods of acid-fast bacilli (AFB) smear and culture. The aim of this study was to determine if the Xpert MTB/rifampicin (RIF) assay had additional advantages over nested PCR for the detection of MTB in a geographical area with intermediate tuberculosis (TB) incidence.
Methods: Between February and December 2013, the Xpert MTB/RIF assay and MTB nested PCR, as well as AFB smear and culture, were simultaneously performed on 198 clinical samples (160 pulmonary and 38 non-pulmonary specimens) collected from 171 patients hospitalized at Hallym University Medical Center for possible TB. The accuracy of the diagnosis of MTB culture-positive TB and the turnaround time of reporting laboratory results were calculated and compared. Rifampin resistance by the Xpert MTB/RIF assay was reviewed with that of conventional drug susceptibility testing (DST).
Results: The sensitivity, specificity, and positive and negative predictive values of the Xpert MTB/RIF assay and MTB nested PCR for diagnosis of MTB culture-positive pulmonary TB were 86.1% vs. 69.4% (P=0.1563), 97.8% vs. 94.1% (P=0.2173), 91.2% vs. 75.8% (P=0.1695), and 96.4% vs. 92.0% (P=0.2032), respectively. The median turnaround times of the Xpert MTB/RIF assay and MTB nested PCR were 0 [0-4] days and 4 [1-11] days, respectively (P<0.001). Two cases of rifampin resistance, as determined by the Xpert MTB/RIF assay, were found to be multi-drug resistant (MDR) pulmonary TB by DST.
Conclusions: The Xpert MTB/RIF assay seemed to be sensitive, specific, and comparable to nested PCR for identifying MTB among clinically suspected TB patients, and the assay can be valuable in giving a timely identification of resistance to rifampin.
Keywords: Mycobacterium tuberculosis (MTB); polymerase chain reaction (PCR); pulmonary tuberculosis.
Similar articles
-
[Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].Mikrobiyol Bul. 2014 Apr;48(2):223-32. doi: 10.5578/mb.7456. Mikrobiyol Bul. 2014. PMID: 24819260 Turkish.
-
Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.PLoS Med. 2011 Jul;8(7):e1001061. doi: 10.1371/journal.pmed.1001061. Epub 2011 Jul 26. PLoS Med. 2011. PMID: 21814495 Free PMC article.
-
Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.PLoS One. 2017 Oct 9;12(10):e0186139. doi: 10.1371/journal.pone.0186139. eCollection 2017. PLoS One. 2017. PMID: 29016684 Free PMC article.
-
Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update.Geneva: World Health Organization; 2013. Geneva: World Health Organization; 2013. PMID: 25473701 Free Books & Documents. Review.
-
Diagnostic test accuracy of Xpert MTB/RIF for tuberculous pericarditis: a systematic review and meta-analysis.F1000Res. 2020 Jul 22;9:761. doi: 10.12688/f1000research.22770.1. eCollection 2020. F1000Res. 2020. PMID: 32802321 Free PMC article.
Cited by
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2019 Jun 7;6(6):CD009593. doi: 10.1002/14651858.CD009593.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2021 Feb 22;2:CD009593. doi: 10.1002/14651858.CD009593.pub5. PMID: 31173647 Free PMC article. Updated.
-
Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Jan 15;1:CD012768. doi: 10.1002/14651858.CD012768.pub3. PMID: 30148542 Free PMC article. Updated.
-
Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients.BMC Infect Dis. 2022 Apr 1;22(1):321. doi: 10.1186/s12879-022-07287-5. BMC Infect Dis. 2022. PMID: 35365080 Free PMC article.
-
Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.New Microbes New Infect. 2017 Jul 13;19:117-120. doi: 10.1016/j.nmni.2017.07.002. eCollection 2017 Sep. New Microbes New Infect. 2017. PMID: 28794886 Free PMC article.
-
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.PLoS One. 2015 Feb 6;10(2):e0116721. doi: 10.1371/journal.pone.0116721. eCollection 2015. PLoS One. 2015. PMID: 25658091 Free PMC article.
References
-
- WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries. Available online: https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2...
-
- Centers for Disease Control and Prevention (CDC) Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009;58:7-10 - PubMed
-
- Jouveshomme S, Cambau E, Trystram D, et al. Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis. Am J Respir Crit Care Med 1998;158:1096-101 - PubMed
LinkOut - more resources
Full Text Sources